Profile data is unavailable for this security.
About the company
Luye Pharma Group Ltd is a company mainly engaged in developing, producing, marketing and selling pharmaceutical products. The Company operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.
- Revenue in HKD (TTM)6.98bn
- Net income in HKD448.92m
- Incorporated2003
- Employees5.12k
- LocationLuye Pharma Group LtdNo.15 Chuangye RoadHigh-Tech Zone, YantaiYANTAI 264003ChinaCHN
- Phone+86 5 356717618
- Fax+86 5 356717718
- Websitehttps://www.luye.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Tong Ren Tang Chinese Medicine | 1.71bn | 515.36m | 7.38bn | 789.00 | 14.33 | 1.83 | 11.76 | 4.32 | 0.6157 | 0.6157 | 2.04 | 4.81 | 0.3878 | 0.4134 | 4.92 | 2,185,246.00 | 12.14 | 15.34 | 13.34 | 17.17 | 63.00 | 68.94 | 31.29 | 39.16 | 11.43 | -- | 0.0327 | 52.52 | 5.69 | 2.38 | -7.42 | -2.09 | 20.50 | 8.76 |
| China Shineway Pharmaceutical Group Ltd | 3.78bn | 936.69m | 8.08bn | 2.87k | 7.88 | 0.9148 | 10.38 | 2.14 | 1.24 | 1.24 | 5.01 | 10.68 | 0.3299 | 1.15 | 3.81 | 1,174,520.00 | 8.17 | 8.29 | 10.75 | 10.38 | 73.36 | 74.83 | 24.77 | 18.67 | 3.39 | -- | 0.0419 | 37.49 | -16.35 | 6.90 | -13.35 | 10.80 | 8.92 | 19.39 |
| CStone Pharmaceuticals | 229.01m | -426.47m | 8.18bn | 93.00 | -- | 21.22 | -- | 35.71 | -0.3272 | -0.3272 | 0.1768 | 0.2611 | 0.1487 | 1.38 | 1.68 | 1,696,351.00 | -27.69 | -39.13 | -54.45 | -60.19 | -12.18 | 66.69 | -186.23 | -170.86 | 1.20 | -29.83 | 0.554 | -- | -12.21 | -- | 75.16 | -- | -- | -- |
| SSY Group Ltd | 4.58bn | 658.92m | 8.73bn | 5.70k | 13.50 | 1.22 | 7.76 | 1.90 | 0.223 | 0.223 | 1.55 | 2.46 | 0.3616 | 2.27 | 2.11 | 751,065.60 | 5.27 | 9.41 | 6.34 | 12.43 | 42.68 | 56.47 | 14.58 | 17.65 | 2.40 | 14.91 | 0.346 | 42.91 | -10.67 | 4.49 | -19.53 | -1.36 | -8.36 | 9.73 |
| Hbm Holdings Ltd | 904.62m | 571.25m | 10.25bn | 210.00 | 15.92 | 4.23 | 17.14 | 11.33 | 0.7407 | 0.7407 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,798,829.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.63bn | -299.51m | 10.27bn | 15.58k | -- | 0.4388 | 11.31 | 0.5827 | -0.0595 | -0.0595 | 3.50 | 4.65 | 0.4326 | 1.59 | 1.71 | 1,052,279.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Luye Pharma Group Ltd | 6.98bn | 448.92m | 10.67bn | 5.12k | 22.37 | 0.6044 | 6.67 | 1.53 | 0.1193 | 0.1193 | 1.85 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,354,499.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.70bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
| Guangzhou Innogen Pharmaceutl Grp Co Ltd | -100.00bn | -100.00bn | 12.64bn | 105.00 | -- | 14.88 | -- | -- | -- | -- | -- | 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.39 | -- | 0.0769 | -- | -- | -- | 76.18 | -- | -- | -- |
| Everest Medicines Ltd | 962.76m | -745.02m | 13.52bn | 722.00 | -- | 2.82 | -- | 14.04 | -2.31 | -2.31 | 2.98 | 13.55 | 0.1684 | 13.97 | 3.04 | 1,447,760.00 | -13.03 | -29.28 | -14.21 | -31.67 | 69.92 | -- | -77.38 | -1,040.86 | 5.43 | -- | 0.1577 | -- | 461.16 | -- | -23.32 | -- | 16.96 | -- |
| CF PharmTech Inc | 683.02m | 31.39m | 14.53bn | 574.00 | 463.04 | 13.40 | 141.62 | 21.27 | 0.0762 | 0.0762 | 1.66 | 2.63 | -- | -- | -- | -- | -- | -- | -- | -- | 80.18 | -- | 4.60 | -- | 1.89 | -- | 0.076 | -- | 9.23 | -- | -33.53 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.37bn | -91.19m | 15.00bn | 2.77k | -- | 3.04 | -- | 6.32 | -0.0098 | -0.0098 | 0.2571 | 0.5394 | 0.1894 | 1.49 | 3.86 | 889,501.40 | -3.05 | -3.60 | -5.01 | -5.05 | 66.29 | 73.13 | -16.08 | -19.74 | 1.61 | -1.36 | 0.1606 | -- | 2.18 | -7.96 | -301.10 | -- | -20.58 | 3.60 |
| Consun Pharmaceutical Group Ltd | 3.70bn | 1.14bn | 15.15bn | 3.07k | 13.54 | 3.12 | 12.44 | 4.10 | 1.33 | 1.33 | 4.31 | 5.77 | 0.5642 | 2.35 | 12.33 | 1,167,866.00 | 17.60 | 14.71 | 24.67 | 22.82 | 76.62 | 75.04 | 31.20 | 29.56 | 3.32 | -- | 0.0517 | 40.93 | 14.56 | 11.42 | 16.05 | 62.72 | -9.54 | 25.83 |
Data as of Feb 13 2026. Currency figures normalised to Luye Pharma Group Ltd's reporting currency: Hong Kong Dollar HKD
12.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 20 Jan 2026 | 186.42m | 4.67% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 79.10m | 1.98% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 51.56m | 1.29% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 41.56m | 1.04% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 41.30m | 1.03% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2025 | 29.64m | 0.74% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 28.38m | 0.71% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 26.16m | 0.66% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 16.24m | 0.41% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2025 | 13.78m | 0.35% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
